AU researchers, Daniel Otzen, Hossein Mohammad-Beigi, and Cagla Sahin and collaborators publish in ACS Nano on how the design of nanoparticles have a crucial role in the inhibition of alpha-synuclein fibrillation and the progress of Parkinson’s Disease, accordingly.